Induction of adipocyte hyperplasia in subcutaneous fat depot alleviated type 2 diabetes symptoms in obese mice

Obesity

Volumn 22, Issue 7, 2014, Pages 1623-1631

  Lu, Qiqi ^a   Li, Mingming ^a   Zou, Yu ^a   Cao, Tong ^a  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

Adipose tissue; Insulin resistance; Mouse model; Type 2 diabetes

Indexed keywords

ADIPONECTIN; FATTY ACID; INSULIN; RESISTIN; TRIACYLGLYCEROL;

ADIPOCYTE; ADIPOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AREA UNDER THE CURVE; ARTICLE; C57BL 6 MOUSE; CELL DENSITY; CONTROLLED STUDY; GENE EXPRESSION; GLUCOSE TOLERANCE; HYPERPLASIA; INSULIN SENSITIVITY; LIPID STORAGE; MALE; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PATHOGENESIS; PROTEIN BLOOD LEVEL; SUBCUTANEOUS FAT; SYMPTOM; ANIMAL; C57BL MOUSE; COMPLICATION; INSULIN RESISTANCE; INTRAABDOMINAL FAT; LIPID DIET; METABOLISM; MOUSE MUTANT; PATHOLOGY; PROTECTION;

MUS;

ADIPOCYTES; ANIMALS; DIABETES MELLITUS, TYPE 2; DIET, HIGH-FAT; HYPERPLASIA; INSULIN RESISTANCE; INTRA-ABDOMINAL FAT; MALE; MICE; MICE, INBRED C57BL; MICE, OBESE; OBESITY; PROTECTIVE FACTORS; SUBCUTANEOUS FAT;

EID: 84903523582     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1002/oby.20705     Document Type: Article

References (28)

1. Goran MI, Ball GD, Cruz ML,. Obesity and risk of type 2 diabetes and cardiovascular disease in children and adolescents. J ClinEendocrinol Metab 2003; 88: 1417-1427.
2. Eckel RH, Kahn SE, Ferrannini E, et al. Obesity and type 2 diabetes: what can be unified and what needs to be individualized? J Clin Endocrinol Metab 2011; 96: 1654-1663.
3. Haffner SM,. Relationship of metabolic risk factors and development of cardiovascular disease and diabetes. Obesity 2006; 14: 121S-127S.
4. Gastaldelli A, Miyazaki Y, Pettiti M, et al. Metabolic effects of visceral fat accumulation in type 2 diabetes. J Clin Endocrinol Metab 2002; 87: 5098-5103.
5. Bray GA, Jablonski KA, Fujimoto WY, et al. Relation of central adiposity and body mass index to the development of diabetes in the Diabetes Prevention Program. Am J Clin Nutr 2008; 87: 1212-1218.
6. McLaughlin T, Lamendola C, Liu A, Abbasi F,. Preferential fat deposition in subcutaneous versus visceral depots is associated with insulin sensitivity. J Clin Endocrinol Metab 2011; 96: E1756-E1760.
7. Porter SA, Massaro JM, Hoffmann U, Vasan RS, O'Donnel CJ, Fox CS,. Abdominal subcutaneous adipose tissue: a protective fat depot? Diab Care 2009; 32: 1068-1075.
8. Preis SR, Massaro JM, Robins SJ, et al. Abdominal subcutaneous and visceral adipose tissue and insulin resistance in the Framingham heart study. Obesity 2010; 18: 2191-2198.
9. Frederiksen L, Nielsen TL, Wraae K, et al. Subcutaneous rather than visceral adipose tissue is associated with adiponectin levels and insulin resistance in young men. J Clin Endocrinol Metab 2009; 94: 4010-4015.
10. Tran TT, Yamamoto Y, Gesta S, Kahn CR,. Beneficial effects of subcutaneous fat transplantation on metabolism. Cell Metab 2008; 7: 410-420.
11. Hocking SL, Chisholm DJ, James DE,. Studies of regional adipose transplantation reveal a unique and beneficial interaction between subcutaneous adipose tissue and the intra-abdominal compartment. Diabetologia 2008; 51: 900-902.
12. Jo J, Gavrilova O, Pack S, et al. Hypertrophy and/or hyperplasia: dynamics of adipose tissue growth. PLoS Comput Biol 2009; 5: e1000324.
13. Danforth E, Jr,. Failure of adipocyte differentiation causes type II diabetes mellitus? Nature Genet 2000; 26: 13.
14. Sun K, Kusminski CM, Scherer PE,. Adipose tissue remodeling and obesity. J Clin Invest 2011; 121: 2094-2101.
15. Kimura Y, Ozeki M, Inamoto T, Tabata Y,. Time course of de novo adipogenesis in matrigel by gelatin microspheres incorporating basic fibroblast growth factor. Tissue Eng 2002; 8: 603-613.
16. Tabata Y, Miyao M, Inamoto T, et al. De novo formation of adipose tissue by controlled release of basic fibroblast growth factor. Tissue Eng 2000; 6: 279-289.
17. Zhu XH, Tabata Y, Wang CH, Tong YW,. Delivery of basic fibroblast growth factor from gelatin microsphere scaffold for the growth of human umbilical vein endothelial cells. Tissue Eng Part A 2008; 14: 1939-1947.
18. Schmittgen TD, Livak KJ,. Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc 2008; 3: 1101-1108.
19. Mark M, Teletin M, Antal C, et al. Histopathology in mouse metabolic investigations. Curr Protoc Mol Biol 2007;Chapter 29:Unit 29B 24.
20. Kim DH, Sandoval D, Reed JA, et al. The role of GM-CSF in adipose tissue inflammation. Am J Physiol Endocrinol Metab 2008; 295: E1038-E1046.
21. Guilherme A, Virbasius JV, Puri V, Czech MP,. Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes. Nat Rev Mol Cell Biol 2008; 9: 367-377.
22. Yang X, Smith U,. Adipose tissue distribution and risk of metabolic disease: does thiazolidinedione-induced adipose tissue redistribution provide a clue to the answer? Diabetologia 2007; 50: 1127-1139.
23. Edens NK, Fried SK, Kral JG, Hirsch J, Leibel RL,. In vitro lipid synthesis in human adipose tissue from three abdominal sites. Am J Physiol 1993; 265: E374-E379.
24. Reynisdottir S, Dauzats M, Thorne A, Langin D,. Comparison of hormone-sensitive lipase activity in visceral and subcutaneous human adipose tissue. J Clin Endocrinol Metab 1997; 82: 4162-4166.
25. Neeland IJ, Turer AT, Ayers CR, et al. Dysfunctional adiposity and the risk of prediabetes and type 2 diabetes in obese adults. J Am Med Assoc 2012; 308: 1150-1159.
26. Scherer PE,. Adipose tissue: from lipid storage compartment to endocrine organ. Diabetes 2006; 55: 1537-1545.
27. Weyer C, Funahashi T, Tanaka S, et al. Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab 2001; 86: 1930-1935.
28. Meyer LK, Ciaraldi TP, Henry RR, Wittgrove AC, Phillips SA,. Adipose tissue depot and cell size dependency of adiponectin synthesis and secretion in human obesity. Adipocyte 2013; 2: 217-226.